Rituximab to account for 40% of all Intraocular Lymphoma Treatments; Global Market Worth to surpass US$ 1 Billion by 2023-end | FMI Report

The global market for intraocular lymphoma treatment is expected to be worth US$ 1.2 billion by the year of 2023. The market, which is estimated to be worth US$ 2.3 billion by 2033, will grow at a 6.7% CAGR, according to the market intelligence firm, Future Market Insights. Intraocular lymphomas are uncommon cancers that present …

Combined Sales of Infertility Drugs Market Will Cross US$ 6,814.68 million by 2033; Ovulation Disorder is Leading to a Rise in Demand for Infertility Drugs

The global Infertility Drugs Market size was valued at US$ 3,699.8 million in the year 2023 and is projected to grow to US$ 6,814.68 million by 2033. This market is expected to register a CAGR of 6.3% during the analysis period. Due to the increase in infertility, a rise in the demand for infertility drugs …

Laband Syndrome Therapeutics Market to reach US$ 5 Billion by 2033, expanding at a 5.2% CAGR | Reports FMI

A recently published study by FMI expects the global Laband Syndrome Therapeutics Market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 5 Billion is expected for the market. Rising awareness of rare diseases and increased attention to heredity-related problems in the …

Thrombocytopenia Treatment Market Value to reach US$ 10 Billion by 2033; expected to surge at over 5% CAGR : FMI Report

A recently published study by FMI expects the global Thrombocytopenia Treatment Market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 10 Billion is expected for the market. The thrombocytopenia treatment market is predicted to increase significantly, since patients with thrombocytopenia experience …

The preservation of critical infrastructural projects usually requires the implementation of Structural Health Monitoring Systems in South Korea

Considerations about the safety of engineering structures and critical infrastructure are unavoidable, as damage to the latter has a significant economic impact on both live people and property. As a result, concerns about damage safeguards are one of the major drivers of revenue in the Structural Health Monitoring Market in Korea. The lowering of essential …

Healthcare Firms in South Korea Bet on Affordable and Comprehensive Keratitis Treatment Regimens as Patients Seek Extended Insurance Coverage

As per a report published by Future Market Insights, Korea is anticipated to expand at around 5.3% CAGR in the global Keratitis Treatment Market from 2023 to 2033. The healthcare industry in Korea is rapidly innovating and developing. With numerous key companies and institutions leading the way, treatments for keratitis are set to become advanced …

Precocious Puberty Treatment Market to reach US$ 3,650.66 million by 2033

The global precocious puberty treatment market is expected to reach an amazing valuation of US$ 1,716.43 million in 2023 and US$ 3,650.66 million by 2033, growing at a 7.8% CAGR during the forecast period. The focus of key industry players on getting product approval from regulatory authorities such as United States Food and Drug Administration …

Large Granular Lymphocytic Leukemia Therapeutics Market to reach US$ 12,700 million by 2033

The global large granular lymphocytic leukemia (LGLL) therapeutics market is expected to surpass an impressive valuation of US$ 2,871.05 million in 2023 and is projected to reach US$ 12,700 million by 2033, trailing a CAGR of 16.03% In addition, the increasing research and development activities and technological development are likely to create various new opportunities …

Glucose Monitoring Devices Market is expected to reach US$ 118.1 Billion by 2033

According to Future Market Insights’ most recent industry report, the global glucose monitoring devices market was valued at roughly US$ 21.3 Billion in 2022 and is expected to rise at a CAGR close to 16.9% over the forecast period, reaching an estimated worth of US$ 118.1 Billion in 2033. Over the past 20 years, diabetes …

Migraine Treatment Market is expected to grow with a 4% CAGR during 2023 to 2033

The global Migraine Treatment Market is predicted to generate a market value of US$ 3.2 billion in 2023 and a market value of US$ 4.74 billion by 2033, with a CAGR of 4% from 2023 to 2033. In the historical period 2018 to 2022, the Migraine Therapy market grew at a CAGR of 3%. The …